Brandywine Global Investment Management’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-70,041
Closed -$18.1M 706
2023
Q4
$18.1M Sell
70,041
-3,408
-5% -$882K 0.15% 158
2023
Q3
$18.9M Buy
73,449
+6,284
+9% +$1.62M 0.17% 152
2023
Q2
$19.1M Buy
67,165
+1,528
+2% +$435K 0.16% 146
2023
Q1
$18.2M Sell
65,637
-2,469
-4% -$686K 0.15% 152
2022
Q4
$18.9M Sell
68,106
-4,854
-7% -$1.34M 0.15% 152
2022
Q3
$19.5M Buy
72,960
+23,831
+49% +$6.36M 0.18% 137
2022
Q2
$10M Sell
49,129
-554
-1% -$113K 0.09% 205
2022
Q1
$10.5M Sell
49,683
-100,637
-67% -$21.2M 0.08% 241
2021
Q4
$36.1M Sell
150,320
-2,688
-2% -$645K 0.26% 108
2021
Q3
$43.3M Buy
153,008
+103,159
+207% +$29.2M 0.33% 85
2021
Q2
$17.3M Buy
49,849
+9,268
+23% +$3.21M 0.13% 173
2021
Q1
$11.4M Sell
40,581
-69,136
-63% -$19.3M 0.09% 258
2020
Q4
$26.9M Sell
109,717
-130,608
-54% -$32M 0.22% 120
2020
Q3
$68.2M Buy
240,325
+57,409
+31% +$16.3M 0.67% 30
2020
Q2
$48.9M Buy
182,916
+15,632
+9% +$4.18M 0.5% 47
2020
Q1
$52.9M Buy
167,284
+158,083
+1,718% +$50M 0.63% 29
2019
Q4
$2.71M Buy
9,201
+9,112
+10,238% +$2.68M 0.02% 496
2019
Q3
$21K Sell
89
-36,781
-100% -$8.68M ﹤0.01% 738
2019
Q2
$8.62M Sell
36,870
-176,890
-83% -$41.4M 0.06% 272
2019
Q1
$50.5M Buy
213,760
+21,942
+11% +$5.19M 0.35% 73
2018
Q4
$57.7M Sell
191,818
-1,962
-1% -$590K 0.43% 63
2018
Q3
$68.5M Sell
193,780
-6,041
-3% -$2.13M 0.43% 62
2018
Q2
$58M Sell
199,821
-3,954
-2% -$1.15M 0.37% 72
2018
Q1
$55.8M Buy
203,775
+13,083
+7% +$3.58M 0.35% 71
2017
Q4
$60.7M Buy
190,692
+5,899
+3% +$1.88M 0.36% 69
2017
Q3
$57.9M Sell
184,793
-6,930
-4% -$2.17M 0.37% 66
2017
Q2
$52M Sell
191,723
-1,720
-0.9% -$467K 0.33% 70
2017
Q1
$52.9M Sell
193,443
-290
-0.1% -$79.3K 0.33% 70
2016
Q4
$54.9M Sell
193,733
-90,327
-32% -$25.6M 0.35% 74
2016
Q3
$88.9M Buy
284,060
+121,465
+75% +$38M 0.59% 45
2016
Q2
$39.3M Buy
162,595
+131,238
+419% +$31.7M 0.26% 90
2016
Q1
$8.16M Buy
+31,357
New +$8.16M 0.05% 316